Dongming Yan Selected Research

Dongming Yan Research Topics

Disease

16	Glioma (Gliomas) 02/2024 - 01/2019
13	Neoplasms (Cancer) 03/2024 - 01/2017
8	Cholestasis 02/2024 - 01/2021
6	Glioblastoma (Glioblastoma Multiforme) 01/2024 - 01/2017
3	Necrosis 09/2023 - 01/2021
2	Intrahepatic Cholestasis 09/2023 - 01/2021
2	Liver Diseases (Liver Disease) 09/2023 - 01/2023
2	Jaundice (Icterus) 09/2023 - 01/2021
2	Carcinogenesis 02/2023 - 09/2020
2	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2017
1	Infarction (Infarctions) 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Moyamoya Disease (Moya-Moya Disease) 01/2023
1	Digestive System Diseases 01/2023
1	Meningioma (Meningiomas) 01/2021
1	Edema (Dropsy) 01/2021
1	Brain Ischemia (Cerebral Ischemia) 12/2020
1	Reperfusion Injury 12/2020
1	Hypoxia (Hypoxemia) 01/2019
1	Adenocarcinoma of Lung 01/2017
1	Atherosclerosis 06/2012

Drug/Important Bio-Agent (IBA)

7	Long Noncoding RNAIBA 02/2023 - 01/2017
5	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2019
5	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2023
5	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2019
4	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 02/2024 - 01/2022
3	Messenger RNA (mRNA)IBA 01/2024 - 01/2023
3	Bile Acids and Salts (Bile Acids)IBA 09/2023 - 01/2021
3	Temozolomide (Temodar)FDA LinkGeneric 01/2023 - 01/2017
2	Therapeutic UsesIBA 02/2024 - 01/2023
2	Glycyrrhetinic Acid (Po 12)IBA 02/2024 - 12/2023
2	1-Naphthylisothiocyanate (1 Naphthylisothiocyanate)IBA 02/2024 - 01/2023
2	Caspase 8 (Caspase-8)IBA 12/2023 - 01/2023
2	Indicators and Reagents (Reagents)IBA 12/2023 - 01/2023
2	Cholic AcidIBA 09/2023 - 01/2023
2	yinchenIBA 09/2023 - 01/2021
2	Alanine Transaminase (SGPT)IBA 01/2023 - 01/2021
2	ursodoxicoltaurineIBA 01/2023 - 01/2023
2	isothiocyanic acidIBA 01/2023 - 01/2021
2	Sincalide FDA Link 01/2023 - 01/2019
2	Antisense RNA (Anti-Sense RNA)IBA 09/2020 - 01/2019
2	CateninsIBA 09/2020 - 06/2019
1	Antineoplastic Agents (Antineoplastics)IBA 03/2024
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2024
1	Cycloheximide (Cicloheximide)IBA 02/2024
1	Eosine Yellowish-(YS) (Eosin)IBA 02/2024
1	Hematoxylin (Haematoxylon)IBA 02/2024
1	DNA (Deoxyribonucleic Acid)IBA 01/2024
1	Transaminases (Aminotransferases)IBA 09/2023
1	EnzymesIBA 09/2023
1	Capsules (Microcapsules)IBA 03/2023
1	dihydrotanshinone IIBA 03/2023
1	Ethanol (Ethyl Alcohol)IBA 03/2023
1	LigandsIBA 02/2023
1	ApoferritinsIBA 01/2023
1	Antisense OligonucleotidesIBA 01/2023
1	CCAAT-Enhancer-Binding ProteinsIBA 01/2023
1	CaspasesIBA 01/2023
1	Circular RNAIBA 01/2023
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	obeticholic acidIBA 01/2023
1	LuteolinIBA 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2023
1	Taurocholic Acid (Sodium Taurocholate)IBA 04/2022
1	glycyrrhizae radix et rhizomaIBA 01/2021
1	BilirubinIBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Alkaline PhosphataseIBA 01/2021
1	CytokinesIBA 12/2020
1	Small Nucleolar RNA (snoRNA)IBA 01/2020
1	Karyopherins (Importin)IBA 01/2020
1	Fluorescein (Funduscein)FDA LinkGeneric 04/2019
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2019
1	IronIBA 01/2019
1	LuciferasesIBA 01/2019
1	Emodin (Archin)IBA 06/2012

Therapy/Procedure

4	Therapeutics 12/2023 - 01/2023
3	Immunotherapy 12/2023 - 01/2022
2	Radiotherapy 01/2024 - 01/2021